Scleroderma renal crisis presents with the abrupt onset of severe hypertension accompanied by rapidly progressive renal failure, hypertensive encephalopathy, congestive heart failure,Â and/or microangiopathic hemolytic anemia. RAAS activation plays a crucial role in the pathogenesis of scleroderma renal crisis, and use of angiotensin-converting enzyme inhibitors (ACEIs) 1-year mortality which was 85% before the use of these drugs has dropped to 24% with the use of these drugs. Therefore, the current practice is to lower blood pressure rapidly with ACEIs and maintain it.